T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$6.08B |
| 2 |
PayPal
PYPL
|
+$722M |
| 3 |
JNPR
Juniper Networks
JNPR
|
+$712M |
| 4 |
FITB
Fifth Third Bancorp
FITB
|
+$692M |
| 5 |
Morgan Stanley
MS
|
+$644M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$5.54B |
| 2 |
Vipshop
VIPS
|
+$825M |
| 3 |
Honeywell
HON
|
+$813M |
| 4 |
Estee Lauder
EL
|
+$804M |
| 5 |
GE Aerospace
GE
|
+$787M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.49% |
| 2 | Consumer Discretionary | 15.06% |
| 3 | Financials | 13.94% |
| 4 | Technology | 11.82% |
| 5 | Industrials | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDAS
2126
DELISTED
MEDASSETS INC COM STK (DE)
MDAS
| $317K | ﹤0.01% |
10,260
+160
| +2% | +$4.45K |
|
2127
Genesco
GCO
$391M
| $316K | ﹤0.01% |
5,560
+60
| +1% | +$3.47K |
|
|
GHDX
2128
DELISTED
Genomic Health, Inc.
GHDX
| $315K | ﹤0.01% |
+8,950
| New | +$240K |
|
|
IRC
2129
DELISTED
INLAND REAL ESTATE CORP
IRC
| $313K | ﹤0.01% |
29,500
+200
| +0.7% | +$1.87K |
|
2130
Caleres
CAL
$455M
| $312K | ﹤0.01% |
11,640
+110
| +1% | +$3.21K |
|
2131
Chord Energy
CHRD
$7.53B
| $311K | ﹤0.01% |
42,166
-15,300
| -27% | -$164K |
|
2132
Green Plains
GPRE
$1.06B
| $311K | ﹤0.01% |
+13,600
| New | +$288K |
|
2133
Lindsay Corp
LNN
$1.18B
| $310K | ﹤0.01% |
4,280
+30
| +0.7% | +$2.08K |
|
2134
Gogo Inc
GOGO
$383M
| $309K | ﹤0.01% |
+17,360
| New | +$295K |
|
2135
Sabra Healthcare REIT
SBRA
$5.16B
| $308K | ﹤0.01% |
15,233
+200
| +1% | +$4.21K |
|
2136
Thomson Reuters
TRI
$44.5B
| $308K | ﹤0.01% |
7,043
-2,867
| -29% | -$133K |
|
|
CRC
2137
DELISTED
California Resources Corporation
CRC
| $307K | ﹤0.01% |
13,188
-53,200
| -80% | -$1.92M |
|
2138
Arrow Financial
AROW
$725M
| $306K | ﹤0.01% |
14,268
+38
| +0.3% | +$835 |
|
2139
Atara Biotherapeutics
ATRA
$83.1M
| $306K | ﹤0.01% |
464
-1,152
| -71% | -$871K |
|
2140
Regis Corp
RGS
$69.3M
| $306K | ﹤0.01% |
1,080
+385
| +55% | +$117K |
|
2141
ATI
ATI
$31.4B
| $305K | ﹤0.01% |
27,067
-12,776
| -32% | -$176K |
|
2142
Andersons Inc
ANDE
$2.23B
| $304K | ﹤0.01% |
9,620
+2,370
| +33% | +$81.8K |
|
2143
Hovnanian Enterprises
HOV
$793M
| $302K | ﹤0.01% |
6,668
-633
| -9% | -$30.4K |
|
2144
Kulicke & Soffa
KLIC
$4.98B
| $301K | ﹤0.01% |
25,800
-12,560
| -33% | -$137K |
|
2145
Vanguard FTSE Developed Markets ETF
VEA
$238B
| $301K | ﹤0.01% |
8,200
| – | – |
|
|
CTCT
2146
DELISTED
CONSTANT CONTACT, INC COM
CTCT
| $301K | ﹤0.01% |
10,280
+80
| +0.8% | +$2.31K |
|
2147
Benchmark Electronics
BHE
$2.94B
| $300K | ﹤0.01% |
14,515
-10,760
| -43% | -$228K |
|
2148
Caesars Entertainment
CZR
$6.04B
| $300K | ﹤0.01% |
27,318
+100
| +0.4% | +$966 |
|
2149
Universal Electronics
UEIC
$75.8M
| $300K | ﹤0.01% |
5,840
+40
| +0.7% | +$1.94K |
|
|
TBI
2150
Trueblue
TBI
$302M
| $299K | ﹤0.01% |
11,610
+110
| +1% | +$2.97K |
|
Similar funds
T. Rowe Price Associates's Q4 2015 Portfolio in Review
As of Q4 2015, T. Rowe Price Associates held 2,616 positions worth $475B, up 5.8% from $449B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q4 2015 filing shows 108 new, 1,286 increased, 995 reduced and 102 closed positions. Its largest new stake was Alphabet (Google) Class A: 164,207,340 shares worth $6.39B. The largest sale was Alphabet (Google) Class C, an estimated $5.54B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2015 buy was Alphabet (Google) Class A: 164,207,340 shares worth $6.39B.
- T. Rowe Price Associates added most to PayPal in Q4 2015, an estimated $722M increase.
- T. Rowe Price Associates's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $5.54B.
- T. Rowe Price Associates fully exited CYTEC INDS INC in Q4 2015, selling an estimated $610M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $475B portfolio in Q4 2015.
- T. Rowe Price Associates opened 108 new positions and closed 102 in Q4 2015.
- T. Rowe Price Associates's portfolio value rose 5.8% quarter-over-quarter to $475B.
Based on T. Rowe Price Associates's 13F filing for Q4 2015, filed 16 Feb 2016.